Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 24

1.

A mono-carbonyl analog of curcumin induces apoptosis in drug-resistant EGFR-mutant lung cancer through the generation of oxidative stress and mitochondrial dysfunction.

Dai X, Zhang J, Guo G, Cai Y, Cui R, Yin C, Liu W, Vinothkumar R, Zhang T, Liang G, Zhang X.

Cancer Manag Res. 2018 Aug 29;10:3069-3082. doi: 10.2147/CMAR.S159660. eCollection 2018.

2.

Curcumin inhibits proliferation and promotes apoptosis of breast cancer cells.

Hu S, Xu Y, Meng L, Huang L, Sun H.

Exp Ther Med. 2018 Aug;16(2):1266-1272. doi: 10.3892/etm.2018.6345. Epub 2018 Jun 22.

3.
4.

EF24 (a Curcumin Analog) and ZSTK474 Emphasize the Effect of Cabozantinib in Medullary Thyroid Cancer.

Bertazza L, Sensi F, Cavedon E, Watutantrige-Fernando S, Censi S, Manso J, Vianello F, Casal Ide E, Iacobone M, Pezzani R, Mian C, Barollo S.

Endocrinology. 2018 Jun 1;159(6):2348-2360. doi: 10.1210/en.2018-00124.

PMID:
29688429
5.

The Radioprotective Effects of Curcumin and Trehalose Against Genetic Damage Caused By I-131.

Jafarpour SM, Safaei M, Mohseni M, Salimian M, Aliasgharzadeh A, Fahood B.

Indian J Nucl Med. 2018 Apr-Jun;33(2):99-104. doi: 10.4103/ijnm.IJNM_158_17. Erratum in: Indian J Nucl Med. 2018 Jul-Sep;33(3):268.

6.

Effects of different extracts of curcumin on TPC1 papillary thyroid cancer cell line.

Perna A, De Luca A, Adelfi L, Pasquale T, Varriale B, Esposito T.

BMC Complement Altern Med. 2018 Feb 15;18(1):63. doi: 10.1186/s12906-018-2125-9.

7.

Effects of nutraceuticals on anaplastic thyroid cancer cells.

Allegri L, Rosignolo F, Mio C, Filetti S, Baldan F, Damante G.

J Cancer Res Clin Oncol. 2018 Feb;144(2):285-294. doi: 10.1007/s00432-017-2555-7. Epub 2017 Dec 2.

PMID:
29197967
8.

Erratum to: Curcumin induces G2/M arrest, apoptosis, NF-κB inhibition, and expression of differentiation genes in thyroid carcinoma cells.

Schwertheim S, Wein F, Lennartz K, Worm K, Schmid KW, Sheu-Grabellus SY.

J Cancer Res Clin Oncol. 2017 Jul;143(7):1155-1156. doi: 10.1007/s00432-017-2403-9. No abstract available.

PMID:
28434042
9.

Curcumin induces G2/M arrest, apoptosis, NF-κB inhibition, and expression of differentiation genes in thyroid carcinoma cells.

Schwertheim S, Wein F, Lennartz K, Worm K, Schmid KW, Sheu-Grabellus SY.

J Cancer Res Clin Oncol. 2017 Jul;143(7):1143-1154. doi: 10.1007/s00432-017-2380-z. Epub 2017 Mar 6. Erratum in: J Cancer Res Clin Oncol. 2017 Jul;143(7):1155-1156.

PMID:
28265769
10.
11.

Curcumin suppresses 4-hydroxytamoxifen resistance in breast cancer cells by targeting SLUG/Hexokinase 2 pathway.

Geng C, Li J, Ding F, Wu G, Yang Q, Sun Y, Zhang Z, Dong T, Tian X.

Biochem Biophys Res Commun. 2016 Apr 22;473(1):147-153. doi: 10.1016/j.bbrc.2016.03.067. Epub 2016 Mar 21.

PMID:
27012210
12.

Curcumin inhibits metastasis in human papillary thyroid carcinoma BCPAP cells via down-regulation of the TGF-β/Smad2/3 signaling pathway.

Zhang L, Cheng X, Gao Y, Zhang C, Bao J, Guan H, Yu H, Lu R, Xu Q, Sun Y.

Exp Cell Res. 2016 Feb 15;341(2):157-65. doi: 10.1016/j.yexcr.2016.01.006. Epub 2016 Jan 27.

PMID:
26826337
13.

Induction of ROS-independent DNA damage by curcumin leads to G2/M cell cycle arrest and apoptosis in human papillary thyroid carcinoma BCPAP cells.

Zhang L, Cheng X, Gao Y, Bao J, Guan H, Lu R, Yu H, Xu Q, Sun Y.

Food Funct. 2016 Jan;7(1):315-25. doi: 10.1039/c5fo00681c.

PMID:
26442630
14.

Zn(II)-curc targets p53 in thyroid cancer cells.

Garufi A, D'Orazi V, Crispini A, D'Orazi G.

Int J Oncol. 2015 Oct;47(4):1241-8. doi: 10.3892/ijo.2015.3125. Epub 2015 Aug 13.

15.

Combinatorial anticancer effects of curcumin and sorafenib towards thyroid cancer cells via PI3K/Akt and ERK pathways.

Zhang J, Yu J, Xie R, Chen W, Lv Y.

Nat Prod Res. 2016 Aug;30(16):1858-61. doi: 10.1080/14786419.2015.1074229. Epub 2015 Aug 24.

PMID:
26299635
16.

Radiosensitive effect of curcumin on thyroid cancer cell death induced by radioiodine-131.

Hosseinimehr SJ, Hosseini SA.

Interdiscip Toxicol. 2014 Jun;7(2):85-8. doi: 10.2478/intox-2014-0011. Epub 2014 Nov 15.

17.

Curcumin inhibits hypoxia-induced migration in K1 papillary thyroid cancer cells.

Tan C, Zhang L, Cheng X, Lin XF, Lu RR, Bao JD, Yu HX.

Exp Biol Med (Maywood). 2015 Jul;240(7):925-35. doi: 10.1177/1535370214555665. Epub 2014 Oct 27.

18.

Curcumin inhibits the invasion of thyroid cancer cells via down-regulation of PI3K/Akt signaling pathway.

Xu X, Qin J, Liu W.

Gene. 2014 Aug 10;546(2):226-32. doi: 10.1016/j.gene.2014.06.006. Epub 2014 Jun 6.

PMID:
24910117
19.

Curcumin Enhances Docetaxel-Induced Apoptosis of 8505C Anaplastic Thyroid Carcinoma Cells.

Hong JM, Park CS, Nam-Goong IS, Kim YS, Lee JC, Han MW, Choi JI, Kim YI, Kim ES.

Endocrinol Metab (Seoul). 2014 Mar;29(1):54-61. doi: 10.3803/EnM.2014.29.1.54. Epub 2014 Mar 14.

20.

Curcumin inhibits invasion and metastasis in K1 papillary thyroid cancer cells.

Zhang CY, Zhang L, Yu HX, Bao JD, Sun Z, Lu RR.

Food Chem. 2013 Aug 15;139(1-4):1021-8. doi: 10.1016/j.foodchem.2013.02.016. Epub 2013 Feb 16.

PMID:
23561205

Supplemental Content

Loading ...
Support Center